Intratumor administration of the photosensitizer Pc 4 affords photodynamic therapy efficacy and selectivity at short drug-light intervals

Translational Oncology

Volumn 3, Issue 2, 2010, Pages 135-141

  Foster, Thomas H ^a   Giesselman, Benjamin R ^a   Hu, Rui ^b   Kenney, Malcolm E ^c   Mitra, Soumya ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROFORM; PHOTOSENSITIZING AGENT; PHTHALOCYANINE PHOTOSENSITIZER PC 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CONTROL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG SELECTIVITY; FEMALE; FLUORESCENCE IMAGING; FLUORESCENCE SPECTROSCOPY; IMAGE ANALYSIS; IN VIVO STUDY; IRRADIATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY;

EID: 77953408156     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.09295     Document Type: Article

References (30)

1. Morton CA, McKenna KE, and Rhodes LE (2008).British Association of Dermatologists Therapy Guidelines and Audit Subcommittee Guidelines for topical photodynamic therapy: update. Br J Dermatol 159, 1245-1266.
2. Mackenzie GD, Dunn JM, Selvasekar CR, Mosse CA, Thorpe SM, Novelli MR, Bown SG, and Lovat LB (2009). Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy. Lasers Med Sci 24, 729-734.
3. Beck TJ, Kreth FW, Beyer W, Mehrkens JH, Obermeier A, Stepp H, Stummer W, and Baumgartner R (2007). Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg Med 39, 386-393.
4. Pichlmeier U, Bink A, Schackert G, Stummer W, and the ALA Glioma Study Group (2008). Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10, 1025-1034.
5. Kostron H, Bellnier DA, Lin CW, Swartz MR, and Martuza RL (1986). Distribution, retention, and phototoxicity of hematoporphyrin derivative in a rat glioma. Intraneoplastic versus intraperitoneal injection. J Neurosurg 64, 768-774.
6. Amano T, Prout GR, and Lin C-W (1988). Intratumor injection as a more effective means of porphyrin administration for photodynamic therapy. J Urol 139, 392-395.
7. Lin C-W, Amano T, Rutledge AR, Shulok JR, and Prout GR (1988). Photodynamic effect in an experimental bladder tumor treated with intratumor injection of hematoporphyrin derivative. Cancer Res 48, 6115-6120.
8. Gibson SL, Van Der Meid KR, Murant RS, and Hilf R (1990). Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II. Br J Cancer 61, 553-557.
9. DiSanto AR and Wagner JG (1972). Pharmacokinetics of highly ionized drugs. III. Methylene blue-blood levels in the dog and tissue levels in the rat following intravenous administration. J Pharm Sci 61, 1090-1094.
10. König K, Bockhorn V, Dietel W, and Schubert H (1987). Photochemotherapy of animal tumors with the photosensitizer methylene blue using a krypton laser. J Cancer Res Clin Oncol 113, 301-303.
11. Orth K, Russ D, Beck G, Rück A, and Beger HG (1998). Photochemotherapy of experimental colonic tumours with intra-tumorally applied methylene blue. Langenbecks Arch Surg 383, 276-281.
12. Orth K, Beck G, Genze F, and Rück A (2000). Methylene blue mediated photodynamic therapy in experimental colorectal tumors in mice. J Photochem Photobiol B 57, 186-192.
13. Orth K, Rück A, Stanescu A, and Berger HG (1995). Intraluminal treatment of inoperable oesophageal tumours by intralesional photodynamic therapy with methylene blue. Lancet 345, 519-520.
14. D'Hallewin MA, Kochetkov D, Viry-Babel Y, Leroux A, Werkmeister E, Dumas D, Gräfe S, Zorin V, Guillemin F, and Bezdetnaya L (2008). Photodynamic therapy with intratumoral administration of lipid-based mTHPC in a model of breast cancer recurrence. Lasers Surg Med 40, 543-549.
15. Mannino S, Molinari A, Sabatino G, Ciafrè SA, Colone M, Maira G, Anile C, Arancia G, and Mangiola A (2008). Intratumor vs. systemic administration of meta-tetrahydroxyphenylchlorin for photodynamic therapy of malignant gliomas: assessment of uptake and spatial distribution in C6 rat glioma model. Int J Immunopathol Pharmacol 21, 227-231.
16. Miller JD, Baron ED, Scull H, Hsia A, Berlin JC, McCormick T, Colussi V, Kenney ME, Cooper KD, and Oleinick NL (2007). Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies. Toxicol Appl Pharmacol 224, 290-299.
17. Holmes HJ, Kennedy JC, Pottier R, Rossi R, and Weagle G (1995). A recipe for the preparation of a rodent food that eliminates chlorophyll-based tissue fluorescence. J Photochem Photobiol B 29, 199.
18. Cummings RJ, Mitra S, Lord EM, and Foster TH (2008). Antibody-labeled fluorescence imaging of dendritic cell populations in vivo. J Biomed Opt 13, 044041.
19. Anula HM, Berlin JC, Wu H, Li Y-S, Peng X, Kenney ME, and Rodgers MAJ (2006). Synthesis and photophysical properties of silicon phthalocyanines with axial siloxy ligands bearing alkylamine termini. J Phys Chem 110, 5215-5223.
20. Finlay JC, Conover DL, Hull EL, and Foster TH (2001). Porphyrin bleaching and PDT-induced spectral changes are irradiance dependent in ALA-sensitized normal rat skin in vivo. Photochem Photobiol 73, 54-63.
21. Bigelow CE, Conover DL, and Foster TH (2003). Confocal fluorescence spectroscopy and anisotropy imaging system. Opt Lett 28, 695-697.
22. Mitra S and Foster TH (2008). In vivo confocal fluorescence imaging of the intratumor distribution of the photosensitizer mono-L-aspartylchlorin-e6. Neoplasia 10, 429-438.
23. Anderson CY, Freye K, Tubesing KA, Li Y-S, Kenney ME, Mukhtar H, and Elmets CA (1998). A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice. Photochem Photobiol 67, 332-336.
24. Lee TK, Baron ED, and Foster TH (2008). Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy. J Biomed Opt 13, 030507.
25. Wang KK-H, Wilson JD, Kenney ME, Mitra S, and Foster TH (2007). Irradiation-induced enhancement of Pc 4 fluorescence and changes in light scattering are potential dosimeters for Pc 4-PDT. Photochem Photobiol 83, 1-7.
26. Bai L, Guo J, Bontempo FA, and Eiseman JL (2009). The relationship of Phthalocyanine 4 (Pc 4) concentrations measured noninvasively to outcome of Pc 4 photodynamic therapy in mice. Photochem Photobiol 85, 1011-1019.
27. Krosl G, Korbelik M, and Dougherty GJ (1995). Induction of immune cell infiltration into murine SCCVII tumour by Photofrin-based photodynamic therapy. Br J Cancer 71, 549-555.
28. Sun J, Cecic I, Parkins CS, and Korbelik M (2002). Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours. Photochem Photobiol Sci 1, 690-695.
29. Gollnick SO, Evans SS, Baumann H, Owczarczak B, Maier P, Vaughan L, Wang WC, Unger E, and Henderson BW (2003). Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 88, 1772-1779.
30. Brown EB, Campbell RB, Tsuzuki Y, Xu L, Carmeliet P, Fukumura D, and Jain RK (2001). In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med 7, 864-868.